Convergen secures $15 million Seed+ financing led by MPCi to advance therapeutics for protein aggregation diseases.
Amount Raised
$15 Million
Round Type
Seed
Investors
Description
Convergen, a biotechnology company, announced the closing of a $15 million Seed+ financing round. The funds will be used to advance Convergen's proprietary degrader platform and accelerate its pipeline for neurodegenerative disorders. This round includes participation from LAV, BioTrack Capital, and a leading biotech fund. Convergen aims to bring new therapeutic options to patients with neurodegenerative diseases and other conditions driven by pathological protein aggregates.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Convergen that raised within 45 days of this round, from Fundz verified event records.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Float Bio raised $140K (Pre-Seed) on October 15, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- seragy holding GmbH raised $13M on October 14, 2026.
- Undecimal Bio raised $18M (Seed) on October 13, 2026.
Who to call at Convergen, and when
A new round usually means Convergen is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Convergen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Convergen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Convergen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Convergen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Convergen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.